With a little luck, Teva will have the case wrapped up in their favor by 2015 and they can incorporate the 180-day Truvada revenue into their three-year EPS guidance! They won’t even have to pay overtime to their attorneys :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.